Back

Safety and efficacy of new antiplatelet drugs in elderly patients with acute coronary syndrome (SCENARIO I study)

15 October 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Antithrombotic therapy Antithrombotic agents ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Doctor Luis Maria Madrona Jimenez

University Hospital of Virgen Macarena, Seville (Spain)

10 More presentations in this session

Presentation thumbnail
Protocol-based management of warfarin pharmacotherapy by pharmacists in perioperative cardiac surgery patients
Mr M. Suzuki (Kamogawa, JP)
Abstract
Presentation thumbnail
High on-treatment after aspirin loading dose platelet reactivity as a modifiable risk factor to tailor antiplatelet therapy in acute coronary syndrome
Professor L. Malinova (Saratov, RU)
Abstract Slides
Presentation thumbnail
Prognostic impact of single antiplatelet therapy as a primary prevention strategy in the acute coronary syndromes setting
Doctor L. Almeida Morais (Lisbon, PT)
Abstract
Presentation thumbnail
Acute coronary syndrome and atrial fibrillation: benefit versus risk of triple antithrombotic therapy
Doctor S. Guerreiro (Lisbon, PT)
Abstract
Presentation thumbnail
Dual antiplatelet therapy in acute coronary syndrome, how long should we maintain it?
Mrs M. Merchan Cuenda (Badajoz, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Antithrombotic therapy

The Event

Event poster

Acute Cardiovascular Care 2016

15 October - 17 October 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources